📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test. (2019)

First Author: González-Billalabeitia E

Attributed to: Leveraging circulating tumour DNA (ctDNA) to dissect the evolutionary genomic dynamics of drug resistance in prostate cancer. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41391-018-0098-x

PubMed Identifier: 30413805

Publication URI: http://europepmc.org/abstract/MED/30413805

Type: Journal Article/Review

Volume: 22

Parent Publication: Prostate cancer and prostatic diseases

Issue: 2

ISSN: 1365-7852